Clinics across England are promoting seasonal discounts on liquid Brazilian butt lifts (BBLs) for Black Friday, drawing sharp criticism from medical professionals and advertising watchdogs who argue these offers trivialize serious health risks.
A liquid BBL involves injecting dermal filler into the buttocks to alter shape. Plastic surgeons warn that the procedure carries significant dangers, including blood clots, fat embolisms, and sepsis, particularly when large volumes of filler are used. The government is currently consulting on regulations that would restrict these treatments to qualified healthcare professionals, a move accelerated by the 2024 death of Alice Webb, a 33-year-old mother who died after a botched procedure in a Gloucester salon.
Regulatory crackdown on promotional tactics
The Advertising Standards Authority (ASA) has previously taken action against time-limited promotions for cosmetic procedures, stating that such offers can pressure consumers into making hasty decisions without adequate consultation. Between April and December 2025, the watchdog identified more than 900 advertisements for liquid BBLs. Only 11.5% of the ads reviewed complied with ASA rules, which prohibit trivializing risks or exploiting body insecurities.
Many of the non-compliant ads made unsubstantiated claims, such as promising a “0% infection rate” or describing the procedures as “safe.” Others used language designed to boost confidence or transform bodies effortlessly, ignoring the potential for devastating complications.
Ashton Collins, director of Save Face, a government-approved register for accredited practitioners, expressed outrage at the marketing of these treatments as “party-season bargains.” She noted that Save Face has received over 1,000 patient complaints regarding non-surgical BBLs since 2023. More than half of those complainants developed sepsis, 94% required hospital treatment, and 43% needed further surgery.
Clinics defend marketing strategies
Despite the backlash, several London-based clinics continue to advertise aggressive discounts. Clinic Blvd recently promoted a 48-hour deal offering 800ml of filler plus 200ml free for £1,300. The advertisement, which featured an image of a woman’s buttocks, claimed demand was at an “all time high” and implied exclusivity. A spokesperson for the clinic stated that patient safety and informed consent remain top priorities, emphasizing that all treatments require individual clinical assessments.
De Vere Signature Aesthetics also offered a limited-time promotion including 100ml of free filler. Their pricing structure rewards customers for choosing larger volumes, with costs dropping from approximately £5 per ml to £1.50 per ml at higher quantities. The Belle Clinic advertised a 40% discount on liquid BBLs to help customers “get ready” for Christmas parties, though a spokesperson clarified that the offer was not intended to create urgency.
Medical experts argue that volume-based pricing and time-limited discounts are dangerous. Nora Nugent, a consultant plastic surgeon and former president of the British Association of Aesthetic Plastic Surgeons (BAAPS), described these tactics as sales ploys that encourage quick decisions. Gerard Lambe, another BAAPS spokesperson, stated that encouraging higher volumes at reduced prices is the “worst thing” a clinic can do, as it directly increases the risk of complications.
Lambe acknowledged that some private surgeons offer deals, noting that affordability issues can drive patients toward cheaper, riskier options abroad. However, he maintained that financial incentives should never override clinical safety.
The ASA continues to enforce its rules on social responsibility in advertising, targeting ads that exploit insecurities or create false urgency. A spokesperson for the regulator said they support further government measures to regulate the sector and ensure that consumers are fully informed before undergoing non-surgical procedures.
Source: The Guardian

